Porous pacemaker electrode tip using a porous substrate

• US 4,784,161 A
• Filed: 11/24/1986
• Issued: 11/15/1988
• Est. Priority Date: 11/24/1986
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Telectronics Incorporated
• Inventors: Millijasevic, Zoran, Nakazawa, Akira, Skalsky, Michael, Gotthardt, Gerhard
• Primary Examiner(s): Cohen, Lee S.
• Application Number:
  US06/933,998
• Time in Patent Office: 722 Days
• Field of Search: 128/784-786, 128/642, 128/419 P
• US Class Current: 607/116
• CPC Class Codes: A61N 1/0565 Electrode heads

Abstract

An implantable stimulating lead for a cardiac pacemaker has a distal tip having a surface area adapted to physically contact heart tissue for pacing the heart tissue, sensing heart contractions and promoting tissue ingrowth. The distal tip includes a conductive electrode and a porous non-conductive substrate, which together define the surface area of the distal tip. The conductive electrode and porous substrate are provided as first and second members, although the surface area of each is adapted to present a singular, smooth distal tip region for the electrode lead.

Claims

1. An implantable stimulating lead for a cardiac pacemaker having a proximal end adapted to be connected to a pulse generator and a distal tip region having a surface area adapted to physically contact heart tissue for stimulating heart tissue in-growth, sensing heart contractions and promoting tissue ingrowth, said distal tip region comprising:

a first member defining a conductive electrode having a conductive first surface area forming a first portion of said distal tip surface area, to stimulate heart tissue and sense heart contractions; and

a second member defining a non-conductive substrate having a second surface area forming a second portion of said distal tip surface area for promoting tissue ingrowth, and attachment of said distal tip to heart tissue,

said second member including a soluble compound disposed in said substrate for rendering said substrate non-porous until after implantation in the heart tissue whereupon said compound dissolves so as to render said substrate and said second surface area porous.

2. A lead according to claim 1, wherein said soluble compound comprises a bioactive agent dispersed in said substrate, said agent diffusing out of said substrate into the heart tissue so as to render said substrate porous.